The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations
about
Roles of MicroRNA across Prenatal and Postnatal PeriodsLong noncoding RNAs in the progression, metastasis, and prognosis of osteosarcomaRhesus macaque IFITM3 gene polymorphisms and SIV infection.Archaic Adaptive Introgression in TBX15/WARS2.Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular diseaseEstablishment of an Immortalized Skin Keratinocyte Cell Line Derived from the Animal Model Mastomys coucha.Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma.Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomasAn Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas.Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.Polymorphisms and mutations in the melanocortin-3 receptor and their relation to human obesity.Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients.Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate.The role of alternative splicing in cancer.Serum microRNA profiling in patients with glioblastoma: a survival analysis.The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs.Long Non-coding RNAs in Prostate Cancer with Emphasis on Second Chromosome Locus Associated with Prostate-1 Expression.RNA Structural Dynamics As Captured by Molecular Simulations: A Comprehensive Overview.Signaling Pathways Driving Aberrant Splicing in Cancer Cells.How Ribosomes Translate Cancer.Mitochondrial mutations in human cancer: Curation of translation.Case-control pharmacogenetic study of HCN1/HCN2 variants and genetic generalized epilepsies.Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing.IGF2 mRNA binding protein 3 (IMP3) mediated regulation of transcriptome and translatome in glioma cells.Systematic evaluation of paediatric cohort with iron refractory iron deficiency anaemia (IRIDA) phenotype reveals multiple TMPRSS6 gene variations.Pan-cancer analysis of somatic mutations and transcriptomes reveals common functional gene clusters shared by multiple cancer types.Deciphering the roles of lncRNAs in breast development and disease.The HUSH complex cooperates with TRIM28 to repress young retrotransposons and new genes.
P2860
Q28070336-CEA1D67B-D077-4929-9232-5C49EA5C1845Q28072875-B34A6D4F-9049-48FF-ADF5-21A518BA1A55Q30361340-0D579692-6B57-47C7-91DD-AE1478F01272Q33681777-BAC8CFB3-0D2F-41D0-ABB9-70F918DD209BQ33895047-4B36D8E5-5AD5-4A98-AA70-ED86B4055837Q36105931-973CAFF4-8446-4A02-B2CB-0B5E63E2A137Q37449688-5281CECC-4354-4430-93AC-C6CD1EADE1CCQ37612511-EF5C63F6-E83C-4837-81EE-DC0357E837D0Q37670401-B8D865CD-4782-4F88-A77B-0AE97D75B948Q38735671-D871E03D-4343-4C48-B3B4-F9F3A0BC59D8Q39211927-FD589E4C-173E-461A-9E58-5273E48A7B55Q39256785-12A84F4C-4727-4265-8DB9-ABF3177F9DC0Q41177221-41F89706-41DB-49F7-BEF1-0512F141D330Q41812457-EB365950-CC06-4D35-ACDA-CB68B8270748Q42251890-11B25E39-5216-4E39-B41B-D95EAD5C1EA5Q42282317-82B6115D-478C-4459-A0F7-FE5764BD530EQ42317085-77FF9791-391E-4DDD-86E2-1B2FF5281098Q47101298-136E4B08-7F29-44E3-B118-0587F3E0F0BDQ47193237-8798822D-FEE7-4EF3-A62A-2B7D2CEB7DFFQ47235409-EDA76B03-4F45-4479-908D-40190908F718Q47246029-45485ACB-E4E1-40C2-8D27-3A2DACD43D7AQ47782255-A92F0608-A97F-4AC5-A35C-50762A483990Q48033166-955CAEF7-E200-4975-8A3C-2A7D3C39BF1BQ48163958-4F42309A-C24E-4438-8921-B997EB6A12C1Q48786445-E85095A3-3D69-4E14-B4E4-05AB2B539260Q51013033-D487A871-54C3-48BF-83CD-30589A8452FCQ51148883-3E2610C0-B23C-4E5F-8646-3300E9AFAF3DQ52718930-10BD8758-FCE6-46AE-A8C9-6E8EA11385BFQ54975879-43815801-C417-42E4-97E7-E6175513E72DQ55204321-59ED97EB-971F-4EE6-92B7-69DF64436941
P2860
The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
The dark matter of the cancer ...... g RNA and synonymous mutations
@ast
The dark matter of the cancer ...... g RNA and synonymous mutations
@en
The dark matter of the cancer ...... g RNA and synonymous mutations
@nl
type
label
The dark matter of the cancer ...... g RNA and synonymous mutations
@ast
The dark matter of the cancer ...... g RNA and synonymous mutations
@en
The dark matter of the cancer ...... g RNA and synonymous mutations
@nl
prefLabel
The dark matter of the cancer ...... g RNA and synonymous mutations
@ast
The dark matter of the cancer ...... g RNA and synonymous mutations
@en
The dark matter of the cancer ...... g RNA and synonymous mutations
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
The dark matter of the cancer ...... g RNA and synonymous mutations
@en
P2093
Anna Steinmann
Danny Jazmati
Deetje Iggena
Jacqueline Wasmuth
Johannes Morstein
Julia C Berkmann
Karin Fröse
Lorenz Bartsch
Ludger Sandig
Maximilian Schell
P2860
P304
P3181
P356
10.15252/EMMM.201506055
P407
P50
P5008
P577
2016-05-02T00:00:00Z